Intravenous Lidocaine and Immunity

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Intravenous Lidocaine and Immunity trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT06923787

Effect of Perioperative Intravenous Infusion of Lidocaine on the Postoperative Course and the Immune Response in Patient…

There are very few data in the literature on changes in inflammatory markers when lidocaine is administered perioperatively in patients with colorectal cancer.…

Slovenia100 participantsStarted 2026-02-03

Treatment: Lidocaine, Placebo

All recent trials (3 shown)

UnknownPhase 4

NCT03410836

Impact of Intravenous Lidocaine During Colorectal Surgery on Pain and Immune Functions

This study evaluates the impact of intraoperative intravenous lidocaine administered during laparoscopic colorectal surgery on the intraoperative remifentanil c…

Canada60 participantsStarted 2019-04-29

Treatment: intravenous lidocaine (IVL), Placebo

CompletedNot Applicable

NCT05484687

Effect of Intravenous Infusion of Lidocaine on Patients Undergoing Radical Resection of Colorectal Tumors

Colorectal cancer (CRC) is one of the most common malignant tumors in the world. Surgical resection is the main treatment option for colorectal cancer patients.…

China100 participantsStarted 2020-03-24

Treatment: Administer 1.5 mg/kg intravenously to the patient before induction of anesthesia, and continue to infuse 1.5 mg/kg/h during the operation until the end of the operation